Ottawa's ketamine therapy market reset substantially in 2024–2025. Braxia Health Ottawa — long the city's primary dedicated ketamine clinic — closed in December 2024 after its parent company's insolvency. Field Trip Health Ottawa continues to operate at 350 Sparks Street near Parliament Hill. FlowState Therapy at 171 Nepean Street emerged as the leading independent provider, offering ketamine-assisted psychotherapy at $800 per session with insurance support for major plans. The Royal Ottawa Mental Health Centre operates a hospital-affiliated Spravato (esketamine) clinic. For federal public servants, the Public Service Health Care Plan (PSHCP), administered via Canada Life, provides a Spravato prior-authorization pathway specific to Ottawa's distinctive workforce. This guide explains Ottawa's current landscape honestly — including how ATMA CENA fits in.
Key takeaways
- Active independent Ottawa providers (May 2026): Field Trip Health Ottawa (350 Sparks St), FlowState Therapy (171 Nepean St), Behavioural Wellness Clinic (554 King Edward Ave), The Royal Ottawa Mental Health Centre (Spravato clinic).
- Braxia Health Ottawa closed December 2024 — do not list as active.
- Ottawa's federal-public-servant workforce makes the PSHCP/Canada Life Spravato pathway (Form M7520) more accessible here than in most Canadian cities.
- WSIB Ontario covers ketamine on multiple specialty formularies for compensable injuries.
ATMA CENA in Ottawa: an honest picture
ATMA CENA operates corporate clinics in Edmonton and Calgary plus a member-clinic network across Alberta, Ontario, Manitoba, Saskatchewan, and Quebec. ATMA CENA's Ottawa member clinic is listed as Focus Forward Therapy Group, but the clinic is in transition (the operator's website rebranded to focusforward.health and currently shows a launch placeholder). Operational status at the time of this article requires verification with ATMA CENA team.
The honest framing for an Ottawa patient researching ketamine therapy:
- Independent Ottawa providers offer locally accessible options for patients who need ketamine therapy now.
- The PSHCP/Canada Life Spravato pathway is a meaningful coverage option for federal public servants and is more accessible in Ottawa than in most Canadian cities.
What is ketamine-assisted therapy?
Ketamine therapy uses sub-anaesthetic doses of ketamine — a Health Canada-approved anaesthetic — to treat conditions including treatment-resistant depression, PTSD, anxiety, OCD, and chronic pain. Health Canada has approved ketamine as an anaesthetic; psychiatric use is off-label, a legal and common practice in Canadian medicine. Spravato (intranasal esketamine) is Health Canada-approved for treatment-resistant MDD as of May 2020.
When ketamine is paired with structured psychotherapy before, during, and after dosing, the treatment is called ketamine-assisted psychotherapy (KAP) or ketamine-assisted therapy (KAT). For the full mechanism breakdown, see What Is Ketamine Therapy?.
How ketamine works
Ketamine acts on the brain's glutamate system through NMDA (N-methyl-D-aspartate) receptor antagonism, triggering a downstream surge of glutamate, AMPA receptor activation, and BDNF (brain-derived neurotrophic factor) release that stimulates synaptogenesis — the formation of new neural connections within 24 to 72 hours of a dose (Lullau et al., 2023). Conventional antidepressants take 4 to 6 weeks to act; ketamine can produce antidepressant effects within 2 to 72 hours of a single IV dose. The Canadian Network for Mood and Anxiety Treatments (CANMAT) places IV racemic ketamine as a third-line treatment for adults with treatment-resistant depression (TRD) (Swainson et al., 2021).
Ottawa's ketamine landscape — May 2026
The Ottawa market has reset since 2024. Active providers:
FlowState Therapy — 171 Nepean Street, Suite 600 (downtown Ottawa). Established post-Braxia closure as Ottawa's leading independent KAP provider. Pricing: $800/session for psychedelic-assisted psychotherapy (2.5 hours); $500/session nurse-led; preparation/integration sessions $170/session. Insurance support: explicitly works with Canada Life (PSHCP), Sun Life, Blue Cross, Veterans Affairs Canada, Green Shield, Manulife. No referral required. Specializes in veterans and first responders.
Field Trip Health Ottawa — 350 Sparks Street, Suite 708 (5-minute walk from Parliament Hill). Despite Field Trip Health & Wellness's 2023 corporate restructuring, the Ottawa clinic continues to operate. Phone (613) 912-5333. Services: ketamine-assisted psychotherapy, IM and intranasal options. No pricing published — discovery call required.
Behavioural Wellness Clinic — 554 King Edward Avenue. KAP with academic/research orientation; preparation, dosing support, integration; clinician training program. No pricing published.
The Royal Ottawa Mental Health Centre — BMO Innovative Clinic for Depression — Spravato (esketamine) nasal spray for severe treatment-resistant depression. Hospital-affiliated; psychiatrist referral required. Treatment costs approximately $800/session and is not OHIP-covered — patients rely on private insurance (the PSHCP pathway is particularly relevant here for federal public servants). The clinic is connected to the University of Ottawa Institute of Mental Health Research, including pioneering Canadian TRD research.
Dr. Patrice Langlois Pain Management (Gatineau, across the Ottawa River) — IV ketamine infusions for refractory neuropathic pain and, with psychiatric/GP referral, psychiatric indications. Phone (819) 243-2221.
Closed: Braxia Health Ottawa (1081 Carling Ave) ceased operations December 2024 following its parent company's insolvency. Patients seeking continuity have largely migrated to FlowState Therapy.
Not in Ottawa: The Ottawa Hospital does not operate a dedicated outpatient ketamine program. CHEO (Children's Hospital of Eastern Ontario) is involved in adolescent ketamine research but is not an adult outpatient access point.
Federal public servants and the PSHCP Spravato pathway
Ottawa is home to roughly one third of Canada's federal public service. The Public Service Health Care Plan (PSHCP), administered by Canada Life, provides Spravato (esketamine) prior-authorization coverage via Form M7520 (current version dated March 2024).
Eligibility criteria typical of the form:
- Diagnosis of moderate-to-severe MDD requiring urgent psychiatric care, or treatment-resistant depression
- Documented failure of two or more antidepressant trials at adequate dose and duration
- Spravato administered in combination with an oral SSRI or SNRI
- Administration in a certified clinical setting under direct healthcare supervision (Janssen Journey program)
- Plan member must first apply through the applicable provincial drug program if eligible
The Royal Ottawa's Spravato clinic and FlowState Therapy (Canada Life accepted) are the most natural delivery pathways for federal public servants pursuing this coverage. PSHCP reimburses prescription drugs at 80% of the lowest-priced generic alternative as of January 2024 — patients should expect partial out-of-pocket cost even with PSHCP approval.
For full PSHCP and broader insurance navigation, see Insurance Coverage for Ketamine Therapy.
Ontario regulatory framework
Federal — Health Canada. Ketamine is a Schedule I controlled substance, prescribed off-label for psychiatric use. Spravato is Health Canada-approved for treatment-resistant MDD as of May 2020.
Provincial — CPSO. The College of Physicians and Surgeons of Ontario (CPSO) governs IV/IM ketamine through the Out-of-Hospital Premises Inspection Program (OHPIP). CPSO standards require physicians qualified to provide deep sedation; clinics must be CPSO-accredited out-of-hospital premises (OHPs).
OHIP, ODB, WSIB, and Ottawa-relevant insurance
OHIP: Covers physician consultations but not ketamine drug or administration for psychiatric indications.
Ontario Drug Benefit (ODB) / Exceptional Access Program: Spravato is not on the standard ODB formulary. EAP requests via SADIE portal — case-by-case.
WSIB Ontario: Covers ketamine and Spravato on multiple specialty formularies (musculoskeletal, CNS/PNS, psychotraumatic, chronic pain, serious injury) with prior authorization for compensable injuries.
PSHCP/Canada Life: Spravato prior authorization (Form M7520) — particularly relevant for Ottawa's federal workforce.
Veterans Affairs Canada: Covers ketamine as a non-formulary product for service-related TRD or chronic pain on a case-by-case basis.
Note: Alberta Blue Cross's psychedelic-assisted therapy coverage does not extend to Ontario residents.
What does ketamine therapy cost in Ottawa?
| Provider | Per-session cost (CAD) | Notes |
|---|---|---|
| FlowState Therapy | $800 | Psychedelic-assisted psychotherapy, 2.5 hrs; insurance covers up to $562.50; PSHCP/Canada Life accepted |
| FlowState Therapy (nurse-led) | $500 | 120-minute nurse-led ketamine session |
| FlowState prep/integration | $170 | 50-minute therapy sessions; often covered by extended health |
| Field Trip Health Ottawa | Not published | Discovery call required |
| The Royal Ottawa Spravato Clinic | ~$800 | Hospital-affiliated; not OHIP-covered; PSHCP and private insurance pathways |
| ATMA CENA KAT (via information call routing) | $1,530–$6,930 | ATMA CENA's published KAT pricing applies network-wide |
For the full Canadian pricing breakdown, see Ketamine Therapy Cost in Canada.
Who is a candidate?
Most Canadian ketamine clinics use the following inclusion criteria:
- Adults 18 or older
- Diagnosis of TRD (failure of 2+ adequate antidepressant trials), bipolar depression with mood-stabilizer coverage, PTSD, anxiety disorders, OCD, or chronic pain
- Medically stable; able to provide informed consent
Absolute contraindications: active psychosis, uncontrolled severe hypertension, severe cardiovascular disease, current pregnancy, anaphylactic reaction to ketamine, active manic episode. For full eligibility detail, see How to Qualify for Ketamine Therapy in Canada.
Local Ottawa practical notes
- Population: ~1.5M Ottawa-Gatineau metro
- Major hospitals: The Ottawa Hospital (Civic, General, Riverside), Children's Hospital of Eastern Ontario, The Royal Ottawa Mental Health Centre, Montfort Hospital (francophone)
- Federal capital: large public service workforce; PSHCP coverage relevance
- Bilingual service area: ~30% French-speaking; some clinics offer service in French
- Transit: OC Transpo, O-Train Confederation Line
- Cross-border note: Gatineau (Quebec) options are accessible via Ottawa River bridges; Quebec's CMQ regulatory framework applies to providers based in Gatineau
- Post-session: 24-hour no-driving rule; arrange a designated driver, rideshare, or transit
Frequently asked questions
Does ATMA CENA have a clinic in Ottawa? ATMA CENA's listed Ottawa member clinic is Focus Forward Therapy Group. The operator's website has rebranded to focusforward.health and currently shows a launch placeholder; operational status should be confirmed with the ATMA CENA team before booking. Ottawa patients can still access the ATMA CENA model via the coordinated care approach — an existing Ottawa-area therapist remains the primary therapeutic relationship while ATMA CENA's network provides medical oversight and dosing infrastructure.
What happened to Braxia Health Ottawa? Braxia Health Ottawa closed in December 2024 following its parent company's insolvency. Patients seeking continuity have largely migrated to FlowState Therapy at 171 Nepean Street.
Does PSHCP cover Spravato for federal public servants in Ottawa? Yes — PSHCP via Canada Life covers Spravato (esketamine) with prior authorization (Form M7520). Eligibility typically requires a confirmed TRD diagnosis, documented failure of two antidepressant trials, and Spravato administered alongside an oral SSRI/SNRI in a certified clinical setting. Reimbursement is at 80% of the lowest-priced generic equivalent.
Does OHIP cover ketamine therapy? OHIP covers physician consultations but not the ketamine drug or administration for psychiatric use. The Royal Ottawa's Spravato clinic is not OHIP-covered for the drug itself; patients rely on PSHCP, private insurance, or self-pay.
What is the cheapest way to access ketamine therapy in Ottawa? For eligible federal public servants with PSHCP, Spravato at The Royal Ottawa or a Canada Life-accepting clinic is often the most cost-efficient pathway. For self-pay patients, FlowState Therapy's $800/session (with insurance support) and integration session pricing of $170 are competitive.
Do I need a doctor's referral? FlowState Therapy and most independent Ottawa private clinics accept self-referrals. The Royal Ottawa Spravato clinic requires a psychiatrist referral. Discuss with ATMA CENA team during the information call.
Can I drive after a ketamine session? No. Patients cannot drive for at least 24 hours after a session. OC Transpo and rideshare are the practical Ottawa alternatives.
Are there public hospital ketamine programs in Ottawa? The Royal Ottawa offers Spravato through its hospital-affiliated BMO Innovative Clinic for Depression — but treatment is not OHIP-covered (private insurance and PSHCP apply). The Ottawa Hospital does not operate a dedicated outpatient ketamine program.
Can my Ottawa therapist work with ATMA CENA network? Yes — through coordinated care model. Your therapist can remain the primary therapeutic relationship while ATMA CENA's network provides medical oversight and dosing infrastructure. This is particularly relevant for Ottawa given ATMA CENA's transitional member-clinic status; the coordinated care approach lets Ottawa therapists work with ATMA CENA without requiring a fully operational local ATMA CENA clinic.
Sources
- ATMA CENA — Find care near you: https://psychedelic.healthcare/find-care/
- ATMA CENA — Psychedelic-Assisted Therapy (pricing): https://psychedelic.healthcare/
- CPSO — Out-of-Hospital Premises Inspection Program: https://www.cpso.on.ca/physicians/your-practice/accreditation-programs/out-of-hospital-premises-inspection-program
- WSIB Ontario — Ketamine and Esketamine Formulary Decision: https://www.wsib.ca/en/drug-formulary-listing-decision-ketamine-and-esketamine
- Ontario Exceptional Access Program: https://www.ontario.ca/page/exceptional-access-program
- Health Canada DPD — Spravato: https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98903
- Canada Life — Spravato PSHCP Prior Authorization Form M7520: https://www.welcome.canadalife.com/content/dam/canadalife/documents/forms/you-and-your-family/1-0-employer/1-3-request-an-assessment/1-3-2-prior-auth-drugs/en/pshcp/spravato-m7520.pdf
- PSHCP Member Site — Canada Life: https://www.welcome.canadalife.com/pshcp
- The Royal Ottawa — BMO Innovative Clinic for Depression: https://www.theroyal.ca/news/clinic-represents-new-hope-people-living-difficult-treat-depression
- FlowState Therapy Ottawa: https://www.flowstatetherapy.ca/
- Field Trip Health Ottawa: https://fieldtriphealth.ca/locations/ottawa/
- Lullau APM, et al. (2023). Antidepressant mechanisms of ketamine. Front Neurosci. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1223145/full
- Swainson J, et al. (2021). CANMAT racemic ketamine recommendations. Can J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/33174760/
Related articles in this cluster
- Ketamine Therapy in Canada
- What Is Ketamine Therapy?
- Ketamine Therapy Cost in Canada
- How to Qualify for Ketamine Therapy in Canada
- Ketamine Therapy for Depression
- Ketamine Therapy in Toronto and the GTA
- Ketamine Therapy in Mississauga
- Insurance Coverage for Ketamine Therapy
- Find care near you
Last updated: 2026-05-05